Patent: 7,276,244
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Summary for Patent: 7,276,244
Title: | Methods of treating abnormalities of the first metatarsophalangeal joint of the foot |
Abstract: | Disclosed is a method for treating abnormalities of the first metatarsophalangeal joint of the foot of a mammal comprising administering a therapeutically effective amount of neuromuscular toxin to the mammal. Preferred embodiments include administering toxins capable of interfering with the connection between muscle and nerve, e.g. botulinum toxin, to the patient to treat such abnormalities as hallux abductovalgus, hallux varus, hallux limitus, and hallux rigidus. |
Inventor(s): | Radovic; Philip (San Clemente, CA) |
Assignee: | Radovic; Philip (San Clemente, CA) |
Application Number: | 11/056,382 |
Patent Claims: | see list of patent claims |
Details for Patent 7,276,244
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Solstice Neurosciences, Llc | MYOBLOC | rimabotulinumtoxinb | Injection | 103846 | 12/08/2000 | ⤷ Try a Trial | 2024-02-12 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |